ABEONA THERAPEUTICS INC. Revenues
ABEONA THERAPEUTICS INC. (ABEO) reported Revenues of $0 for the 3-month period ending 2019-06-30, per its 10-Q filed 2019-08-09.
Discontinued › Income Statement › Revenue
us-gaap:Revenues · last filed 2019-08-09
- ABEONA THERAPEUTICS INC. revenues for the quarter ending 2019-06-30 was $0.00, a 100.00% decline year-over-year.
- ABEONA THERAPEUTICS INC. revenues for the quarter ending 2019-03-31 was $0.00, a 100.00% decline year-over-year.
- ABEONA THERAPEUTICS INC. revenues for the quarter ending 2018-12-31 was -$2.13M, a 1089.77% decline year-over-year.
- ABEONA THERAPEUTICS INC. revenues for the quarter ending 2018-09-30 was $1.71M, a 680.37% increase year-over-year.
- ABEONA THERAPEUTICS INC. revenues for fiscal 2018 was $3.00M, a 258.18% increase from fiscal 2017.
- ABEONA THERAPEUTICS INC. revenues for fiscal 2017 was $837.00K, a 5.85% decline from fiscal 2016.
- ABEONA THERAPEUTICS INC. revenues for fiscal 2016 was $889.00K.
| Period end | Revenues 3 month | Revenues 6 month | Revenues 9 month | Revenues 12 month |
|---|---|---|---|---|
| 2019-06-30 | $0.00 10-Q · filed 2019-08-09 | $0.00 10-Q · filed 2019-08-09 | -$2.13M derived: sum of 3 quarters · filed 2019-08-09 | -$419.00K derived: sum of 4 quarters · filed 2019-08-09 |
| 2019-03-31 | $0.00 10-Q · filed 2019-05-10 | -$2.13M derived: sum of 2 quarters · filed 2019-05-10 | -$419.00K derived: sum of 3 quarters · filed 2019-05-10 | -$143.00K derived: sum of 4 quarters · filed 2019-08-09 |
| 2018-12-31 | -$2.13M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-18 | -$419.00K derived: sum of 2 quarters · filed 2019-03-18 | -$143.00K derived: sum of 3 quarters · filed 2019-08-09 | $3.00M 10-K · filed 2019-03-18 |
| 2018-09-30 | $1.71M 10-Q · filed 2018-11-09 | $1.99M derived: sum of 2 quarters · filed 2019-08-09 | $5.13M 10-Q · filed 2018-11-09 | $2.73M derived: sum of 4 quarters · filed 2019-08-09 |
| 2018-06-30 | $276.00K 10-Q · filed 2019-08-09 | $807.00K 10-Q · filed 2019-08-09 | $1.02M derived: sum of 3 quarters · filed 2019-08-09 | $1.24M derived: sum of 4 quarters · filed 2019-08-09 |
| 2018-03-31 | $531.00K 10-Q · filed 2019-05-10 | $746.00K derived: sum of 2 quarters · filed 2019-05-10 | $965.00K derived: sum of 3 quarters · filed 2019-05-10 | |
| 2017-12-31 | $215.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-18 | $434.00K derived: sum of 2 quarters · filed 2019-03-18 | $837.00K 10-K · filed 2019-03-18 | |
| 2017-09-30 | $219.00K 10-Q · filed 2018-11-09 | $622.00K 10-Q · filed 2018-11-09 | ||
| 2016-12-31 | $889.00K 10-K · filed 2019-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GT Biopharma, Inc. (GTBP) | United States | $0.309B | -4.58 |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |
| Evommune, Inc. (EVMN) | United States | $0.320B | -5.10 |
| BridgeBio Oncology Therapeutics, Inc. (BBOT) | United States | $0.320B | -3.35 |
| Vanda Pharmaceuticals Inc. (VNDA) | United States | $0.302B | -1.35 |
| STANDARD BIOTOOLS INC. (LAB) | United States | $0.297B | 3.80 |
| ROCKET PHARMACEUTICALS, INC. (RCKT) | United States | $0.296B | -21.78 |
| BioAge Labs, Inc. (BIOA) | United States | $0.333B | -11.88 |
| Fulcrum Therapeutics, Inc. (FULC) | United States | $0.289B | -3.28 |
| Contineum Therapeutics, Inc. (CTNM) | United States | $0.289B | -4.40 |